Gravenbos Farma

Active Risk: not assessed

Private limited companyfounded 2021active for 5 yearsEsdoornlaan 1, 1770 Liedekerke, BelgiumKBO/BCE: BE 0769.920.078

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Gravenbos Farma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €220,755 and a net result of €80,059. Equity is growing by about 68% per year across the filed financial years. Its solvency ranks better than 30% of 10,789 sector peers (NACE 70, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

Gravenbos FarmaActive

Risk analysis Report Compare

Official details

KBO

Status: Active since 21-06-2021 Normal situation
Legal form: Private limited company
Registered office: Esdoornlaan 1, 1770 Liedekerke
Activity: Activities of head offices NACE 70100and 3 others
Establishment unit: 2.323.102.884 1770 Liedekerke, since 01-10-2021
Financial year end: 31 December
Peppol: Reachable since 21-10-2026

Company details

Who decides

Board

Droeshout KaterinaDirector · since 15-06-2021

Holdings: Shares in 1 company APOTHEEK DAEM

Board & ownership

How it is doing

Holding: outside the score modelBankruptcy probability: sector outside the model

Annual accounts 2025

Gross margin: €139,075; ▲ 4.1%
Turnover: ≈ €230,000; estimated
Profit: €80,059; ▲ 3.7%
Equity: €220,755; ▲ 56.9%
Total assets: €753,836; ▲ 4.5%

2025 accounts filed 31 days late

Filed on 31-08-2026at the National Bank

Financials

Signalsraises risk2025 accounts filed 31 days lateShow the evidence

Checked score

Outside the general model

Holding: general score not applicable

The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.

Bankruptcy probability, 12 months

This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

1 signal.

raises risk

2025 accounts filed 31 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 4 filings

Deviation from the deadline

2025

31 days late

2024

106 days late

2023

30 days late

2022

31 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 50 days after the deadline; the sector median (NACE 70) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (3 of the last 4 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Equity rose in 2025from €140,695 to €220,755 ▲ 56.9% View

Documents

Key facts about Gravenbos Farma

What is the company number of Gravenbos Farma?: 0769.920.078. In Belgium the VAT number is the company number with BE in front: BE 0769.920.078.
Where is Gravenbos Farma based?: The registered office is at Esdoornlaan 1, 1770 Liedekerke.Company details
What does Gravenbos Farma do?: According to the KBO register, the main activity is activities of head offices (NACE 70100).
What is the legal form of Gravenbos Farma?: Private limited company (BV).
When was Gravenbos Farma founded?: On 21-06-2021.
Is Gravenbos Farma still active?: Yes, Gravenbos Farma is an active enterprise in the KBO register.
What is the turnover of Gravenbos Farma?: ≈ €230,000 in financial year 2025. Estimated from the gross margin of €139,075: probably between €180,000 and €300,000, based on 100 comparable companies, NACE 70.Financials
Is Gravenbos Farma profitable?: In financial year 2025, Gravenbos Farma made a profit of €80,059.
Where can I find the annual accounts of Gravenbos Farma?: Gravenbos Farma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Gravenbos Farma due?: By 31-07-2027, for financial year 2026.Timeline